|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...3940414243444546474849...110111» |
- | Biomarker, New P4 trial: Momatec2: Biomarker Guided Treatment in Gynaecological Cancer (clinicaltrials.gov) - Sep 8, 2015
P4, N=1300, Not yet recruiting, Sponsor: Haukeland University Hospital
- Trial withdrawal: Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation. (clinicaltrials.gov) - Sep 5, 2015
P=N/A, N=0, Withdrawn, Sponsor: HaEmek Medical Center, Israel
Not yet recruiting --> Withdrawn
- triptorelin / Generic mfg.
Enrollment open, Trial primary completion date: Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG (clinicaltrials.gov) - Sep 5, 2015
P4, N=200, Recruiting, Sponsor: HaEmek Medical Center, Israel
Not yet recruiting --> Withdrawn Active, not recruiting --> Recruiting | Trial primary completion date: Oct 2015 --> Oct 2016
- RG4733 / Roche
Trial termination, Trial primary completion date, Metastases: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) - Sep 4, 2015
P2, N=43, Terminated, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Recruiting | Trial primary completion date: Oct 2015 --> Oct 2016 Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Aug 2015
- Enrollment change, Head-to-Head: A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=1168, Not yet recruiting, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Aug 2015 N=372 --> 1168
- Trial completion, Enrollment change, Trial primary completion date: The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=186, Completed, Sponsor: Fox Chase Cancer Center
N=372 --> 1168 Recruiting --> Completed | N=300 --> 186 | Trial primary completion date: Jul 2015 --> Jul 2014
- Enrollment open, Trial initiation date: Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=48, Recruiting, Sponsor: KK Women's and Children's Hospital
Recruiting --> Completed | N=300 --> 186 | Trial primary completion date: Jul 2015 --> Jul 2014 Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Jun 2015
- Enrollment open: Effectiveness of Single Step Culture Media and Sequential Culture Media on Blastulation Rate (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=448, Recruiting, Sponsor: Vietnam National University
Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Jun 2015 Not yet recruiting --> Recruiting
- ||| budigalimab (ABBV-181) / AbbVie, tamrintamab pamozirine (SC-003) / AbbVie
New P1 trial, Combination therapy: Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer (clinicaltrials.gov) - Sep 3, 2015
P1, N=108, Recruiting, Sponsor: Stemcentrx
- Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: The Value of HBA in the Evaluation of Idiopathic Infertility (clinicaltrials.gov) - Sep 3, 2015
P=N/A, N=35, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=80 --> 35 | Initiation date: May 2012 --> Nov 2011 | Trial primary completion date: Jan 2015 --> Jan 2012
- Enrollment open: Clinical Tests to Predict the Success of Assisted Reproductive Techniques (clinicaltrials.gov) - Sep 2, 2015
P=N/A, N=600, Recruiting, Sponsor: Martin Blomberg Jensen
Active, not recruiting --> Completed | N=80 --> 35 | Initiation date: May 2012 --> Nov 2011 | Trial primary completion date: Jan 2015 --> Jan 2012 Not yet recruiting --> Recruiting
- ||||| Esmya (ulipristal acetate) / ASKA Pharma, HRA Pharma, Gedeon Richter, AbbVie
Enrollment closed, Trial primary completion date: A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas (clinicaltrials.gov) - Sep 1, 2015
P3, N=150, Active, not recruiting, Sponsor: Watson Pharmaceuticals
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Mar 2016
- Trial completion: ALIFERT: Diet and Its Relationship With Couple Infertility (clinicaltrials.gov) - Sep 1, 2015
P=N/A, N=400, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Mar 2016 Active, not recruiting --> Completed
- Trial completion, Enrollment change: STYLEnS: HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment (clinicaltrials.gov) - Aug 29, 2015
P1/2, N=86, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed Recruiting --> Completed | N=188 --> 86
- bupropion / Generic mfg.
Trial completion: Bupropion in Helping Adults Stop Smoking (clinicaltrials.gov) - Aug 28, 2015
P2, N=97, Completed, Sponsor: Roswell Park Cancer Institute
Recruiting --> Completed | N=188 --> 86 Active, not recruiting --> Completed
- New trial: Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products (clinicaltrials.gov) - Aug 28, 2015
P=N/A, N=50, Recruiting, Sponsor: CONRAD
- New P4 trial: Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients (clinicaltrials.gov) - Aug 28, 2015
P4, N=50, Recruiting, Sponsor: King Chulalongkorn Memorial Hospital
- | Onconase (ranpirnase) / Orgenesis, Leidos
New P2 trial: Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) (clinicaltrials.gov) - Aug 28, 2015
P2, N=50, Not yet recruiting, Sponsor: Tamir Biotechnology, Inc.
- Enrollment open: Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE) (clinicaltrials.gov) - Aug 28, 2015
P1, N=100, Recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial completion: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Aug 28, 2015
P=N/A, N=13, Completed, Sponsor: University of Virginia
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial primary completion date: Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy (clinicaltrials.gov) - Aug 27, 2015
P=N/A, N=39, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Active, not recruiting --> Completed Trial primary completion date: Aug 2015 --> Aug 2016
- || Gendicine (rAd-p53 Gene Therapy) / Benda Pharma
Trial initiation date: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) (clinicaltrials.gov) - Aug 27, 2015
P1, N=59, Completed, Sponsor: Merck Sharp & Dohme Corp.
Trial primary completion date: Aug 2015 --> Aug 2016 Initiation date: Mar 1997 --> Jun 1999
- Enrollment closed: Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (clinicaltrials.gov) - Aug 27, 2015
P=N/A, N=1106, Active, not recruiting, Sponsor: Johns Hopkins Bloomberg School of Public Health
Initiation date: Mar 1997 --> Jun 1999 Recruiting --> Active, not recruiting
- Elonva (corifollitropin alfa) / Organon
Trial primary completion date: MANCOR: Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders (clinicaltrials.gov) - Aug 26, 2015
P4, N=60, Recruiting, Sponsor: IVI Sevilla
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2015 --> Jan 2016
- Enrollment closed: 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy (clinicaltrials.gov) - Aug 25, 2015
P2, N=60, Active, not recruiting, Sponsor: AC Camargo Cancer Center
Trial primary completion date: Sep 2015 --> Jan 2016 Recruiting --> Active, not recruiting
- | New P2 trial: A Mind-body Intervention to Improve Body and/or Self Image (clinicaltrials.gov) - Aug 25, 2015
P2, N=97, Recruiting, Sponsor: University of Michigan
- Trial primary completion date, Surgery: MISSION: Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study (clinicaltrials.gov) - Aug 22, 2015
P2, N=30, Active, not recruiting, Sponsor: Catholic University of the Sacred Heart
Recruiting --> Active, not recruiting Trial primary completion date: Mar 2015 --> Aug 2015
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Trial primary completion date: Mar 2015 --> Aug 2015 Trial primary completion date: Jul 2015 --> Nov 2015
- || Papitrol (tirvalimogene teraplasmid) / Genexine, National OncoVenture
Trial primary completion date: Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Aug 22, 2015
P2, N=72, Recruiting, Sponsor: Genexine, Inc.
Trial primary completion date: Jul 2015 --> Nov 2015 Trial primary completion date: May 2015 --> Dec 2015
- Trial primary completion date: Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=20, Recruiting, Sponsor: Case Comprehensive Cancer Center
Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Aug 2015 --> Feb 2016
- Trial primary completion date: Evaluation of the Endometrial Cavity After Endometrial Ablation (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=25, Terminated, Sponsor: Baylor Research Institute
Trial primary completion date: Aug 2015 --> Feb 2016 Trial primary completion date: Jun 2015 --> Dec 2015
- Trial primary completion date: Fermented Wheat Germ Extract in Women With Ovarian Cancer (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Mar 2016 --> Aug 2016
- Trial primary completion date, Surgery: CILOVE: Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients (clinicaltrials.gov) - Aug 21, 2015
P2, N=47, Recruiting, Sponsor: Centre Jean Perrin
Trial primary completion date: Mar 2016 --> Aug 2016 Trial primary completion date: Jul 2015 --> Sep 2016
- ||||||| Bravelle (urofollitropin) / Ferring
Trial completion, Trial primary completion date, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females (clinicaltrials.gov) - Aug 21, 2015
P3, N=215, Completed, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Jul 2015 --> Sep 2016 Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jul 2015
- New trial: Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: Stanford University
- Menopur (menotropin) / Ferring, Follistim AQ Cartridge (follitropin beta) / Organon
Trial completion, Trial initiation date, Trial primary completion date: Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist (clinicaltrials.gov) - Aug 21, 2015
P4, N=188, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jul 2015 Recruiting --> Completed | Initiation date: Jan 2004 --> Jan 2014 | Trial primary completion date: Dec 2015 --> Dec 2014
- Enrollment change, Trial withdrawal, Trial primary completion date: Improving IVF Embryo Quality Grading Using Polarized Light (clinicaltrials.gov) - Aug 20, 2015
P1, N=0, Withdrawn, Sponsor: Hadassah Medical Organization
Recruiting --> Completed | Initiation date: Jan 2004 --> Jan 2014 | Trial primary completion date: Dec 2015 --> Dec 2014 N=200 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2013 --> Aug 2015
- Enrollment change, Trial withdrawal, Trial primary completion date: The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI (clinicaltrials.gov) - Aug 20, 2015
P1, N=0, Withdrawn, Sponsor: Hadassah Medical Organization
N=200 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2013 --> Aug 2015 N=100 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2013 --> Aug 2015
- gemifloxacin mesylate / Generic mfg., azithromycin / Generic mfg., gentamicin sulfate / Generic mfg.
Enrollment change, Combination therapy: Efficacy of Combination Therapies for Gonorrhea Treatment (clinicaltrials.gov) - Aug 20, 2015
P4, N=614, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=100 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2013 --> Aug 2015 N=486 --> 614
- | buparlisib (AN2025) / Novartis, Adlai Nortye
Trial initiation date, Metastases: Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer (clinicaltrials.gov) - Aug 19, 2015
P2, N=27, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
N=486 --> 614 Initiation date: Feb 2016 --> Nov 2015
- Enrollment open: Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=250, Recruiting, Sponsor: Herlev Hospital
Initiation date: Feb 2016 --> Nov 2015 Not yet recruiting --> Recruiting
- ||| New trial: Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=100, Recruiting, Sponsor: Weill Medical College of Cornell University
- ||| New trial: Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=300, Not yet recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI Alicante
- New P1 trial, IO biomarker: Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology (clinicaltrials.gov) - Aug 19, 2015
P1, N=50, Not yet recruiting, Sponsor: University of Toronto
- Trial completion, Enrollment change, Trial primary completion date: LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=10, Completed, Sponsor: Rambam Health Care Campus
Not yet recruiting --> Recruiting Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Dec 2015 --> Aug 2015
- New trial: Transabdominal US-guided (UGET) vs. Modified Transvaginal US-guided (mTVET) Embryo Transfer in Human IVF (clinicaltrials.gov) - Aug 18, 2015
P=N/A, N=1648, Completed, Sponsor: University of Turin, Italy
- propranolol / Generic mfg.
Trial primary completion date, IO biomarker: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients (clinicaltrials.gov) - Aug 17, 2015
P0, N=24, Completed, Sponsor: Washington University School of Medicine
Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Dec 2015 --> Aug 2015 Trial primary completion date: Feb 2014 --> Aug 2014
- polyvalent vaccine-KLH conjugate / MabVax, Avastin (bevacizumab) / Roche
Trial primary completion date, Combination therapy, IO biomarker: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab (clinicaltrials.gov) - Aug 17, 2015
P=N/A, N=22, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Trial primary completion date: Feb 2014 --> Aug 2014 Trial primary completion date: Oct 2015 --> Oct 2016
- || MEDI-3617 / AstraZeneca
Enrollment closed, Trial primary completion date, Combination therapy, Metastases: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Aug 17, 2015
P1, N=116, Active, not recruiting, Sponsor: MedImmune LLC
Trial primary completion date: Oct 2015 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Nov 2015
- New P2/3 trial: Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy (clinicaltrials.gov) - Aug 17, 2015
P2/3, N=30, Enrolling by invitation, Sponsor: Osama Mohammad Ali ElDamshety